THE USE OF ORAL BISPHOSPHONATES IN REFRACTORY SEVERE HYPERCALCEMIA AFTER DENOSUMAB CESSATION.

Bilici ME, Şıklar Z, Ünal E, Taçyıldız N, Aycan Z, Özsu E, Uyanık R, Ceran A, Berberoğlu M.

DOI: 10.4183/aeb.2024.538
Published: 2024-10-01
Container: Acta Endocrinol (Buchar)
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.4183/aeb.2024.538,
  title = {THE USE OF ORAL BISPHOSPHONATES IN REFRACTORY SEVERE HYPERCALCEMIA AFTER DENOSUMAB CESSATION.},
  author = {Bilici ME and  Şıklar Z and  Ünal E and  Taçyıldız N and  Aycan Z and  Özsu E and  Uyanık R and  Ceran A and  Berberoğlu M.},
  year = {2024},
  journal = {Acta Endocrinol (Buchar)},
  doi = {10.4183/aeb.2024.538},
  url = {https://doi.org/10.4183/aeb.2024.538}
}

RIS

TY  - JOUR
TI  - THE USE OF ORAL BISPHOSPHONATES IN REFRACTORY SEVERE HYPERCALCEMIA AFTER DENOSUMAB CESSATION.
AU  - Bilici ME
AU  -  Şıklar Z
AU  -  Ünal E
AU  -  Taçyıldız N
AU  -  Aycan Z
AU  -  Özsu E
AU  -  Uyanık R
AU  -  Ceran A
AU  -  Berberoğlu M.
PY  - 2024
JO  - Acta Endocrinol (Buchar)
DO  - 10.4183/aeb.2024.538
UR  - https://doi.org/10.4183/aeb.2024.538
ER  -

APA

ME, B., Z, Ş., E, Ü., N, T., Z, A., E, Ö., R, U., A, C., & M., B. (2024). THE USE OF ORAL BISPHOSPHONATES IN REFRACTORY SEVERE HYPERCALCEMIA AFTER DENOSUMAB CESSATION.. Acta Endocrinol (Buchar). https://doi.org/10.4183/aeb.2024.538

Source records

europe-pmc · retrieved 2026-09-27T10:40:35.300Z